Cassiopea Announces FDA Acceptance of its New Drug Application for Clascoterone Cream 1%

Lainate, Italy – November 08, 2019 – Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential…Original Article